Skip to main content
OpenTrials

Clinical trial condition

Psoriasis

Explore clinical trials studying Psoriasis. Study availability and eligibility vary by location and protocol.

1,174 public trials 112 recruiting studies
Refine in advanced search Browse all conditions

Psoriasis trial results

Completed

This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is

NCT03635099

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Total Skin and Beauty Dermatology Center, PC Birmingham, Alabama, United States
  • Dermatology Research Associates Los Angeles, California, United States
  • Southern California Dermatology Inc. Santa Ana, California, United States
  • Hamilton Research Alpharetta, Georgia, United States
View all 34 locations
View Trial Details
Completed

Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque Psoriasis

NCT02905006

Conditions
Chronic Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0010 711 Fremont, California, United States
  • Ps0010 708 Los Angeles, California, United States
  • Ps0010 706 Washington D.C., District of Columbia, United States
  • Ps0010 704 West Des Moines, Iowa, United States
View all 41 locations
View Trial Details
Completed

A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen

NCT04149587

Conditions
Psoriasis, Skin Diseases, Skin Diseases, Papulosquamous, +1 more
Locations
  • Bausch Site 009 Nanaimo, British Columbia, Canada
  • Bausch Site 002 Montréal, Manitoba, Canada
  • Bausch Site 001 Winnipeg, Manitoba, Canada
  • Bausch Site 007 Markham, Ontario, Canada
View Trial Details
Completed

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases

NCT03339089

Conditions
Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +19 more
Locations
  • Shenzhen Futian Hospital for rheumatic Diseases /ID# 209340 Shenzhen, Guangdong, China
  • AbbVie China /ID# 164373 Shanghai, Shanghai Municipality, China
  • The First affiliated hospital of chengdu medical university /ID# 210745 Chengdu, Sichuan, China
  • Zhejiang Province People's Hospital /ID# 209342 Hangzhou, Zhejiang, China
View Trial Details

Related conditions